The present study was the second-largest to address ICS (and the largest focusing on CD3/CD8-based ICS, similar to the method validated in colorectal cancer) [8] in gastric cancer and by far the largest study to date to assess prognostic value of KM grade in gastric adenocarcinoma. Here, CD8A is linked to gastric cancer.